{"id":"https://openalex.org/W2414366244","doi":null,"title":"Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats.","display_name":"Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats.","publication_year":1996,"publication_date":"1996-10-01","ids":{"openalex":"https://openalex.org/W2414366244","mag":"2414366244","pmid":"https://pubmed.ncbi.nlm.nih.gov/11224440"},"language":"en","primary_location":{"id":"pmid:11224440","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224440","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068228068","display_name":"Masahiko Funada","orcid":"https://orcid.org/0000-0003-1330-7522","observed_orcids":["https://orcid.org/0000-0003-1330-7522"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Funada","raw_affiliation_strings":["Clinical Pharmacology Branch Division of Intramural Research, National Institute on Drug Abuse, National Institute of Health, P.O. Box 5180, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Branch Division of Intramural Research, National Institute on Drug Abuse, National Institute of Health, P.O. Box 5180, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045595920","display_name":"Toni Shaun Shippenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T.S. Shippenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2502,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.48397654,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"5","first_page":"448","last_page":"453"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.796999990940094},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":1.0},{"id":"https://openalex.org/keywords/morphine-withdrawal","display_name":"morphine withdrawal","score":0.9639999866485596},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9760000109672546},{"id":"https://openalex.org/keywords/conditioned-place-aversion","display_name":"conditioned place aversion","score":0.8989999890327454},{"id":"https://openalex.org/keywords/conditioned-place-preference","display_name":"conditioned place preference","score":0.7760000228881836},{"id":"https://openalex.org/keywords/sch-23390","display_name":"SCH 23390","score":0.8799999952316284},{"id":"https://openalex.org/keywords/raclopride","display_name":"raclopride","score":0.9950000047683716},{"id":"https://openalex.org/keywords/aversive-effects","display_name":"aversive effects","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C2781069445","wikidata":"https://www.wikidata.org/wiki/Q7279814","display_name":"Raclopride","level":4,"score":0.8607325553894043},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6309860944747925},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.617236852645874},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5355731248855591},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5259996652603149},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5096502304077148},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5034202933311462},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.49422624707221985},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4480297863483429},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.4416932463645935},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.4359019994735718},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4347078204154968},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4334331452846527},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4117639660835266},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3919624388217926},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:11224440","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224440","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"},{"id":"mag:2414366244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224440","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2077716415","https://openalex.org/W2022361809","https://openalex.org/W7037471967","https://openalex.org/W4226256805","https://openalex.org/W2018899494","https://openalex.org/W1984943166","https://openalex.org/W2079561253","https://openalex.org/W2162065288","https://openalex.org/W2981183504","https://openalex.org/W2075432773"],"abstract_inverted_index":{"The":[0,135],"role":[1,252],"of":[2,9,16,75,80,101,104,129,195,205,222,233,247,253,263],"dopamine":[3],"(DA)":[4],"receptors":[5,207,259],"in":[6,110,116,124,132,146,160,192,211,219,260],"the":[7,47,56,87,172,182,193,202,220,231,261],"expression":[8,262],"opioid":[10],"dependence":[11],"was":[12,121,157,187],"examined":[13],"by":[14],"use":[15],"an":[17,250],"unbiased":[18],"conditioned":[19,93,143,241],"place":[20,94,144],"preference":[21],"paradigm.":[22],"Male":[23],"Sprague-Dawley":[24],"rats":[25],"were":[26,66,82],"implanted":[27],"s.c.":[28],"with":[29,42,46,96,169],"two":[30,166],"pellets":[31],"containing":[32],"placebo":[33],"or":[34,55,131,149,244],"75mg":[35],"morphine.":[36],"Animals":[37],"received":[38],"one":[39,45],"conditioning":[40,167],"session":[41],"saline":[43],"and":[44,114,174,214],"DA":[48,57],"D1":[49,136,236,258],"receptor":[50,59,89,137,237],"antagonist":[51,60,90,138,156,238],"SCH23390":[52,139],"(0.01-0.05mg,":[53],"s.c.)":[54],"D2":[58,88,206,254],"raclopride":[61,91,130],"(0.25-1.0mg/kg,":[62],"s.c.).":[63],"Conditioning":[64],"sessions":[65,168],"conducted":[67],"4":[68],"days":[69],"after":[70,152],"pellet":[71],"implantation.":[72],"During":[73],"each":[74],"these":[76],"sessions,":[77],"physical":[78,162,227,245],"signs":[79,246],"withdrawal":[81,163,228,248,265],"quantified.":[83],"In":[84],"morphine-pelleted":[85,117],"animals,":[86],"produced":[92],"aversions,":[95],"a":[97,105,178,234],"minimum":[98],"effective":[99],"dose":[100,107],"0.5mg/kg.":[102],"Administration":[103],"higher":[106],"also":[108,158],"resulted":[109],"wet-dog":[111],"shakes,":[112],"ptosis":[113],"diarrhea":[115],"animals.":[118,134],"This":[119,155],"effect":[120,217],"not":[122],"observed":[123],"response":[125],"to":[126,141,239,257],"lower":[127],"doses":[128],"placebo-pelleted":[133,150,175],"failed":[140],"produce":[142,240],"aversions":[145],"either":[147],"morphine-":[148,173],"animals":[151,176,213],"single-trial":[153],"conditioning.":[154],"ineffective":[159],"producing":[161],"signs.":[164,229,266],"After":[165],"SCH23390,":[170],"both":[171],"exhibited":[177],"marked":[179],"aversion":[180],"for":[181],"SCH23390-paired":[183],"place.":[184],"However,":[185],"there":[186],"no":[188],"difference":[189],"between":[190],"groups":[191],"magnitude":[194],"this":[196,216],"effect.":[197],"These":[198],"data":[199],"demonstrate":[200],"that":[201,215],"acute":[203],"blockade":[204],"produces":[208],"aversive":[209,242],"effects":[210,243],"opioid-dependent":[212],"occurs":[218],"presence":[221],"few,":[223],"if":[224],"any,":[225],"prototypic":[226],"Furthermore,":[230],"inability":[232],"selective":[235],"suggests":[249],"important":[251],"as":[255],"compared":[256],"morphine":[264]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}